Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.5064
-0.0220 (-4.16%)
At close: Nov 25, 2025, 4:00 PM EST
0.5125
+0.0061 (1.20%)
Pre-market: Nov 26, 2025, 5:37 AM EST
RVPH Market Cap
RVPH has a market cap or net worth of $58.27 million as of November 26, 2025. Its market cap has increased by 89.28% in one year.
Market Cap
58.27M
Enterprise Value
45.08M
1-Year Change
89.28%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $58.27M, an increase of 131.12%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 58.27M | -30.89% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | 80.73M | 195.66% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |